Hispidulin

Hispidulin is a naturally occurring flavone found in plants such as Salvia and Artemisia species, functioning as a bioactive polyphenol with anti-inflammatory and potential anti-cancer activity. Its primary mechanisms involve suppression of JAK2/STAT3 signaling pathways and inhibition of Th2-driven cytokine release, including IL-4, IL-5, and IL-13.

Origin & History

Hispidulin is a bioflavonoid (flavone subclass) found in various medicinal herbs, particularly Clerodendrum inerme and other plants traditionally used for inflammatory conditions. It is typically isolated from plant materials using standard flavonoid extraction techniques, though specific extraction methods are not detailed in available research.

Historical & Cultural Context

Hispidulin is found in herbs traditionally used in various medicine systems for treating inflammatory diseases, including asthma. The compound is notably isolated from Clerodendrum inerme, which has been historically used for conditions like intractable motor tics, though specific traditional systems and usage duration are not detailed.

Health Benefits

• May reduce allergic inflammation by suppressing Th2 cell differentiation and cytokines (IL-4, IL-5, IL-13) - based on mouse model evidence only • Shows potential anti-cancer properties through apoptosis induction and metastasis inhibition via PIM1/JAK2/STAT3 pathways - limited to cell and animal studies • Could support vascular health by reducing inflammation markers (NF-κB, ICAM-1) and monocyte adhesion - demonstrated only in cell cultures • May offer neuroprotective effects through dopamine elevation via COMT inhibition - shown in mouse behavioral models • Potentially inhibits platelet aggregation through cAMP elevation - based on in vitro studies only

How It Works

Hispidulin inhibits the JAK2/STAT3 and PIM1 signaling axes, reducing transcription of pro-survival and pro-proliferative genes implicated in tumor cell growth and metastasis. In allergic inflammation models, it suppresses Th2 cell differentiation by downregulating GATA-3 expression, thereby reducing secretion of interleukins IL-4, IL-5, and IL-13. Additionally, hispidulin activates intrinsic apoptotic cascades by modulating Bcl-2 family protein ratios, promoting caspase-dependent cell death in cancer cell lines.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on hispidulin. All available evidence comes from preclinical in vitro cell culture studies and in vivo mouse models, including ovalbumin-induced asthma models and colorectal cancer xenografts.

Clinical Summary

The current evidence base for hispidulin consists almost entirely of in vitro cell culture studies and rodent animal models, with no published human clinical trials as of early 2025. In mouse models of allergic airway inflammation, hispidulin reduced eosinophil infiltration and lowered bronchoalveolar IL-5 and IL-13 levels at doses ranging from 10–50 mg/kg. Anti-cancer activity has been demonstrated in cell lines for gastric, ovarian, and hepatocellular carcinoma, with IC50 values typically in the 20–80 µM range, concentrations difficult to achieve clinically through oral supplementation. Overall, evidence strength is preclinical and preliminary; extrapolation to human health outcomes requires significant caution.

Nutritional Profile

Hispidulin is a naturally occurring flavonoid (4',5,7-trihydroxy-6-methoxyflavone), classified as a polymethoxylated flavone with a molecular weight of 300.26 g/mol. It is not a macronutrient or conventional micronutrient — it contains no caloric value, protein, fat, or fiber. As a bioactive polyphenolic compound, it is found in several medicinal herbs including Salvia officinalis, Cirsium japonicum, and Saussurea involucrata, typically at trace concentrations (0.01–0.5% dry weight depending on plant source). Its primary bioactive mechanisms are mediated through flavone-receptor interactions rather than nutritional provision. Bioavailability is considered moderate-to-low due to its hydrophobic character and susceptibility to hepatic first-pass metabolism; lipid co-administration or nanoparticle encapsulation has been shown in preclinical studies to improve absorption. No established dietary reference intake exists. It exhibits antioxidant activity with an IC50 against DPPH radicals reported around 18–45 μM in vitro, comparable to other methoxylated flavones.

Preparation & Dosage

No clinically studied human dosages exist. Animal studies used 10 mg/kg injected intraperitoneally in mice, while cell culture studies employed 1-100 μM concentrations. Human dosing cannot be extrapolated from these preclinical studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Hispidulin pairs well with Quercetin, as both flavonoids converge on NF-κB suppression and STAT3 inhibition, potentially producing additive anti-inflammatory effects while quercetin's broader Nrf2 activation complements hispidulin's cytokine-suppressing (IL-4/IL-5/IL-13) activity. Piperine (from black pepper, ~5–20 mg dose range) is a strong synergistic partner because it inhibits CYP3A4 and P-glycoprotein efflux transporters, directly improving the oral bioavailability of poorly absorbed flavones like hispidulin by an estimated 30–50% based on analogous flavonoid studies. Resveratrol and EGCG (epigallocatechin gallate from green tea) round out the stack by contributing complementary JAK2/STAT3 pathway modulation and apoptosis induction through Bcl-2/Bax ratio shifts, reinforcing hispidulin's observed anti-cancer mechanisms across overlapping but distinct molecular targets.

Safety & Interactions

No human safety trials have been conducted for isolated hispidulin supplementation, making a formal adverse event profile unavailable. Because hispidulin inhibits CYP450 enzymes in vitro, there is a theoretical risk of interactions with drugs metabolized by CYP3A4 and CYP2C9, including warfarin, statins, and certain chemotherapeutics. Pregnant and breastfeeding individuals should avoid hispidulin supplements due to a complete absence of reproductive safety data. Individuals on immunosuppressants or undergoing cancer treatment should consult a physician before use, given its demonstrated immune-modulating and cytotoxic mechanisms.